Martins, Isabelle <br/><br/>
Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.  [electronic resource] 

 -  Melanoma research  Aug 2009 
 - 226-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5636 
<br/><br/><label>Standard No.: </label>10.1097/CMR.0b013e32832e0bc3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers<br/>Cell Line, Tumor<br/>Chemokines--genetics<br/>Disease Progression<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>HLA-DR Antigens--genetics<br/>Humans<br/>Male<br/>Matrix Metalloproteinase 1--genetics<br/>Melanoma--diagnosis<br/>Middle Aged<br/>NF-kappa B--physiology<br/>NF-kappa B p50 Subunit--genetics<br/>Neoplasm Invasiveness--prevention & control<br/>Nuclear Proteins--genetics<br/>Prognosis<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Skin Neoplasms--diagnosis<br/>Trans-Activators--genetics